OncoTICE (bacillus calmette-guerin): Supply issue

Last Updated: 19 February 2025

Supply issue Hospital only Active

Due to a global supply issue there may be a supply issue affecting OncoTICE (Pharmacode: 799629)

19 February 2025 Update

Stock is in the country and available to order. MSD continues to manage the distribution of this product due to on-going limits in availability.

How to order OncoTICE

MSD requires that hospital pharmacists:

use email (do not use electronic EDI)
contact one wholesaler only
order on the first of the month
use the subject line: NZ OncoTICE allocation
include the number of boxes requested and the name of the hospital

MSD notes that this is a request only and pharmacies may not get the quantity requested. Your monthly allocation will be determined by the wholesaler based on historical demand as a portion of the supply available.

7 February 2025 letter from MSD about OncoTICE [PDF, 114 KB]

Affected product

We expect that there will not be a complete out of stock of this product. There is a small amount of this product in the country.

However, stock is low of:

Chemical: Bacillus calmette-guerin (BCG)
Presentation: Inj 2-8 x 100 million CFU
Brand: OncoTICE
Pharmacode: 799629
Subsidy: $149.37
Measure / Qty: per 1

Schedule listing for OncoTICE(external link)

What is happening

Limited stock is available and Pharmac is assessing long-term supply and reviewing alternatives to ensure people can access the treatment they need.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.